HB 1357: Pharmaceutical Take-Back Program Pilot Project
GENERAL BILL by Legg
Pharmaceutical Take-Back Program Pilot Project; Provides that manufacturer of drug may not sell drug or allow drug to be sold in pilot project area unless manufacturer operates pharmaceutical take-back program approved by DOH; provides requirements for such programs; provides requirements for submission of such plan & its approval by DOH; requires retail pharmacies to post sign to inform consumers of availability of pharmaceutical take-back programs, etc.
Effective Date: 07/01/2009
Last Action: 5/2/2009 House - Indefinitely postponed and withdrawn from consideration; Died in Committee on Health Care Regulation Policy (HFPC)
Bill Text: Web Page | PDF
Last Action: 5/2/2009 House - Indefinitely postponed and withdrawn from consideration; Died in Committee on Health Care Regulation Policy (HFPC)
Bill Text: Web Page | PDF
-
Bill History
Date Chamber Action 2/27/2009 House • Filed
3/3/2009 House • Introduced -HJ 00109
3/9/2009 House • Referred to Health Care Regulation Policy (HFPC); Civil Justice & Courts Policy (CCJP); Health & Family Services Policy Council; Full Appropriations Council on General Government & Health Care -HJ 00193
5/2/2009 House • Indefinitely postponed and withdrawn from consideration; Died in Committee on Health Care Regulation Policy (HFPC)
-
HB 1357, Original Filed Version (Current Bill Version) Posted 2/27/2009 at 5:37 PM
Bill Text: Web Page | PDF Analyses: None Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location S 2650 Pharmaceutical Take-back Programs [SPSC] Fasano Similar Last Action: 5/2/2009 S Indefinitely postponed and withdrawn from consideration; Died in Committee on Health Regulation
Location:Citations - Statutes (1)
Citation Catchline Location in Bill Location In Bill Help 499.0295